自己血糖測定装置の世界市場：市場規模・シェア分析 (種類別・用途別・エンドユーザー別)、産業需要の予測 (～2030年)

世界の自己血糖測定 (SMBG) 装置の市場規模は、2023年に253億米ドルに達しました。2024年から2030年にかけて9.7%のCAGRで成長し、最終的に2030年には482億米ドルに達すると予測されています。

この業界の発展は、糖尿病の増加、高齢者人口の増加、技術改良、糖尿病治療に対する意識の高まり、肥満人口の増加などの要因に拠ります。また、英国・米国・イタリア・ドイツ・フランス・日本・スペインなどの国々におけるSMBG装置に対する医療費償還ガイドラインが、業界発展を推進しているもう一つの重要な理由です。

試験紙が引き続き、売上高が最も大きい種類の装置となる

種類別では、2023年に試験紙の販売シェアが40%と最大になりました。このような試験紙は使い捨てのプラスチックから製造され、グルコース酸化物で飽和しており、糖レベルのチェックに役立ちます。これらの有利なグルコース検査用試験紙はまた、血液中のケトンレベルをチェックするために利用することができます。

高齢者と肥満人口の増加による糖尿病頻度の増加

世界の高齢者人口は急速な発展を遂げています。

65歳以上の高齢者の割合は、2022年の10%から2050年には16%に急増すると推定されており、人口動態の大幅な変化が浮き彫りになっています。

この高齢者動向は、SMBG装置産業の発展にとって大きな推進力となります。

北米が市場をリード

2023年には、北米地域が55%という最大のシェアを占めていました。

この圧倒的なシェアの高さは、高血糖の発生が増加し、高齢者人口が増加し、高血糖が北米の実質的な生活習慣病となっていることに起因しています。

また、技術改良と革新的な製品の定期的な発売が、同大陸の業界発展に寄与しています。

当レポートでは、世界の自己血糖測定 (SMBG) 装置の市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (数量・金額ベース、2017～2030年)、種類別・用途別・エンドユーザー別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因/課題
  • 促進要因/抑制要因の影響分析
• 新型コロナウイルス感染症 (COVID-19) の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場規模：種類別 (2017～2030年)
• 市場収益：種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場規模：地域別 (2017～2030年)
• 市場収益：地域別 (2017～2030年)

第7章 北米市場

• 概要
• 市場規模：種類別 (2017～2030年)
• 市場収益：種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)
• 市場規模：国別 (2017～2030年)
• 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ (MEA) 市場

第12章 米国市場

• 概要
• 市場規模：種類別 (2017～2030年)
• 市場収益：種類別 (2017～2030年)
• 市場規模：用途別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場規模：エンドユーザー別 (2017～2030年)
• 市場収益：エンドユーザー別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

• 市場参入企業とその提供製品/サービスの一覧
• 主要企業の競合ベンチマーク
• 主要企業の製品ベンチマーク
• 最近の戦略展開状況

第30章 企業プロファイル

• Johnson & Johnson Services Inc.
• ARKRAY Inc.
• Nova Biomedical
• Bionime Corporation
• Medtronic plc
• B. Braun Melsungen AG
• Abbott Laboratories
• Bayer AG

第31章 付録

In 2023, the worldwide self-monitoring blood glucose devices market accrued revenue of

USD 25.3 billion. It is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% between 2024 and 2030, ultimately reaching USD 48.2 billion by 2030.

This development of the industry is credited to the growing occurrence of diabetes, the rising populace of elderly people, technical improvements, thriving awareness of diabetes care, increasing count of obese populations, and the compensation guidelines for SMBG devices in several nations, such as the U.K., the U.S., Italy, Germany, France, Japan, and Spain, are another significant reason propelling the industry development.

Market Trends

Technical Improvements in SMBG Devices: The worldwide SMBG industry is experiencing a trend of constant technical improvements in SMBG devices. Such innovations comprise the development of new-age instruments that significantly decrease the time taken to test sugar levels compared to traditional lab approaches.

Portability and Convenience: A major trend in the self-monitoring blood glucose devices market is the focus on portability and suitability. Several SMBG devices are made to be compact and simple to carry, offering users better flexibility and convenience in monitoring their blood glucose levels.

Smartphone Integration and Mobile Apps: Another notable trend is the integration of SMBG devices with smartphones and the widespread use of mobile apps. Smartphone apps are playing a crucial role in helping patients manage hyperglycemia by providing education on the condition, promoting healthy lifestyle choices, offering tools for tracking sugar levels, and facilitating medication adherence.

Mobile Sugar Checkers: Companies are increasingly introducing mobile sugar checkers that can be connected to smartphones. These devices allow users to monitor their sugar levels on the go and conveniently access their data through mobile apps, contributing to better management of diabetes and hyperglycemia.

Test Strips Remain the Top-Selling Device Type

In 2023, on the basis of type, the sale of strips had the largest share of 40%. Such strips are manufactured from disposable plastic and saturated with glucose oxides, which aid in checking the sugar level. These lucrative glucose measuring strips can also be utilized for checking the ketone level in the blood.

Increasing Diabetes Frequency with Thriving Elderly and Obese Populations

The worldwide elderly populace is witnessing quick development, as shown by the world population prospects report from the UN.

The share of people elderly 65 years or older is estimated to surge from 10% in 2022 to 16% by 2050, highlighting a substantial demographic shift.

This elderly trend is a major propeller for the development of the self-measuring blood glucose devices industry.

Elderly people are more vulnerable to diabetes in comparison to younger demographics, leading to an augmented need for blood glucose tracking devices between this age group.

North Americans Lead in Diabetes Self-Monitoring and Management

In 2023, the North American region held the largest share, 55%, of the industry.

This dominating regional position can be credited to the increasing occurrence of hyperglycemia and a rising elderly populace, making hyperglycemia a substantial lifestyle disease in North America.

Technical improvements and regular launches of innovative items are contributing to industry development in the continent.

Competition Analysis

For example, in 2022, Dexcom Inc. got FDA clearance for Dexcom G7 for all kinds of hyperglycemic patients ages two years and more in the U.S.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by type
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by end user
  • 1.4.4. Market size breakdown, by region
  • 1.4.5. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Volume
  • 1.5.2. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Volume, by Type (2017-2030)
• 6.3. Market Revenue, by Type (2017-2030)
• 6.4. Market Volume, by Application (2017-2030)
• 6.5. Market Revenue, by Application (2017-2030)
• 6.6. Market Volume, by End User (2017-2030)
• 6.7. Market Revenue, by End User (2017-2030)
• 6.8. Market Volume, by Region (2017-2030)
• 6.9. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Volume, by Type (2017-2030)
• 7.3. Market Revenue, by Type (2017-2030)
• 7.4. Market Volume, by Application (2017-2030)
• 7.5. Market Revenue, by Application (2017-2030)
• 7.6. Market Volume, by End User (2017-2030)
• 7.7. Market Revenue, by End User (2017-2030)
• 7.8. Market Volume, by Country (2017-2030)
• 7.9. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Volume, by Type (2017-2030)
• 8.3. Market Revenue, by Type (2017-2030)
• 8.4. Market Volume, by Application (2017-2030)
• 8.5. Market Revenue, by Application (2017-2030)
• 8.6. Market Volume, by End User (2017-2030)
• 8.7. Market Revenue, by End User (2017-2030)
• 8.8. Market Volume, by Country (2017-2030)
• 8.9. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Volume, by Type (2017-2030)
• 9.3. Market Revenue, by Type (2017-2030)
• 9.4. Market Volume, by Application (2017-2030)
• 9.5. Market Revenue, by Application (2017-2030)
• 9.6. Market Volume, by End User (2017-2030)
• 9.7. Market Revenue, by End User (2017-2030)
• 9.8. Market Volume, by Country (2017-2030)
• 9.9. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Volume, by Type (2017-2030)
• 10.3. Market Revenue, by Type (2017-2030)
• 10.4. Market Volume, by Application (2017-2030)
• 10.5. Market Revenue, by Application (2017-2030)
• 10.6. Market Volume, by End User (2017-2030)
• 10.7. Market Revenue, by End User (2017-2030)
• 10.8. Market Volume, by Country (2017-2030)
• 10.9. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Volume, by Type (2017-2030)
• 11.3. Market Revenue, by Type (2017-2030)
• 11.4. Market Volume, by Application (2017-2030)
• 11.5. Market Revenue, by Application (2017-2030)
• 11.6. Market Volume, by End User (2017-2030)
• 11.7. Market Revenue, by End User (2017-2030)
• 11.8. Market Volume, by Country (2017-2030)
• 11.9. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Volume, by Type (2017-2030)
• 12.3. Market Revenue, by Type (2017-2030)
• 12.4. Market Volume, by Application (2017-2030)
• 12.5. Market Revenue, by Application (2017-2030)
• 12.6. Market Volume, by End User (2017-2030)
• 12.7. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Volume, by Type (2017-2030)
• 13.3. Market Revenue, by Type (2017-2030)
• 13.4. Market Volume, by Application (2017-2030)
• 13.5. Market Revenue, by Application (2017-2030)
• 13.6. Market Volume, by End User (2017-2030)
• 13.7. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Volume, by Type (2017-2030)
• 14.3. Market Revenue, by Type (2017-2030)
• 14.4. Market Volume, by Application (2017-2030)
• 14.5. Market Revenue, by Application (2017-2030)
• 14.6. Market Volume, by End User (2017-2030)
• 14.7. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Volume, by Type (2017-2030)
• 15.3. Market Revenue, by Type (2017-2030)
• 15.4. Market Volume, by Application (2017-2030)
• 15.5. Market Revenue, by Application (2017-2030)
• 15.6. Market Volume, by End User (2017-2030)
• 15.7. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Volume, by Type (2017-2030)
• 16.3. Market Revenue, by Type (2017-2030)
• 16.4. Market Volume, by Application (2017-2030)
• 16.5. Market Revenue, by Application (2017-2030)
• 16.6. Market Volume, by End User (2017-2030)
• 16.7. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Volume, by Type (2017-2030)
• 17.3. Market Revenue, by Type (2017-2030)
• 17.4. Market Volume, by Application (2017-2030)
• 17.5. Market Revenue, by Application (2017-2030)
• 17.6. Market Volume, by End User (2017-2030)
• 17.7. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Volume, by Type (2017-2030)
• 18.3. Market Revenue, by Type (2017-2030)
• 18.4. Market Volume, by Application (2017-2030)
• 18.5. Market Revenue, by Application (2017-2030)
• 18.6. Market Volume, by End User (2017-2030)
• 18.7. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Volume, by Type (2017-2030)
• 19.3. Market Revenue, by Type (2017-2030)
• 19.4. Market Volume, by Application (2017-2030)
• 19.5. Market Revenue, by Application (2017-2030)
• 19.6. Market Volume, by End User (2017-2030)
• 19.7. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Volume, by Type (2017-2030)
• 20.3. Market Revenue, by Type (2017-2030)
• 20.4. Market Volume, by Application (2017-2030)
• 20.5. Market Revenue, by Application (2017-2030)
• 20.6. Market Volume, by End User (2017-2030)
• 20.7. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Volume, by Type (2017-2030)
• 21.3. Market Revenue, by Type (2017-2030)
• 21.4. Market Volume, by Application (2017-2030)
• 21.5. Market Revenue, by Application (2017-2030)
• 21.6. Market Volume, by End User (2017-2030)
• 21.7. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Volume, by Type (2017-2030)
• 22.3. Market Revenue, by Type (2017-2030)
• 22.4. Market Volume, by Application (2017-2030)
• 22.5. Market Revenue, by Application (2017-2030)
• 22.6. Market Volume, by End User (2017-2030)
• 22.7. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Volume, by Type (2017-2030)
• 23.3. Market Revenue, by Type (2017-2030)
• 23.4. Market Volume, by Application (2017-2030)
• 23.5. Market Revenue, by Application (2017-2030)
• 23.6. Market Volume, by End User (2017-2030)
• 23.7. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Volume, by Type (2017-2030)
• 24.3. Market Revenue, by Type (2017-2030)
• 24.4. Market Volume, by Application (2017-2030)
• 24.5. Market Revenue, by Application (2017-2030)
• 24.6. Market Volume, by End User (2017-2030)
• 24.7. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Volume, by Type (2017-2030)
• 25.3. Market Revenue, by Type (2017-2030)
• 25.4. Market Volume, by Application (2017-2030)
• 25.5. Market Revenue, by Application (2017-2030)
• 25.6. Market Volume, by End User (2017-2030)
• 25.7. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Volume, by Type (2017-2030)
• 26.3. Market Revenue, by Type (2017-2030)
• 26.4. Market Volume, by Application (2017-2030)
• 26.5. Market Revenue, by Application (2017-2030)
• 26.6. Market Volume, by End User (2017-2030)
• 26.7. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Volume, by Type (2017-2030)
• 27.3. Market Revenue, by Type (2017-2030)
• 27.4. Market Volume, by Application (2017-2030)
• 27.5. Market Revenue, by Application (2017-2030)
• 27.6. Market Volume, by End User (2017-2030)
• 27.7. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Volume, by Type (2017-2030)
• 28.3. Market Revenue, by Type (2017-2030)
• 28.4. Market Volume, by Application (2017-2030)
• 28.5. Market Revenue, by Application (2017-2030)
• 28.6. Market Volume, by End User (2017-2030)
• 28.7. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. Johnson & Johnson Services Inc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. ARKRAY Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Nova Biomedical
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. Bionime Corporation
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Medtronic plc
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. B. Braun Melsungen AG
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Abbott Laboratories
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Bayer AG
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports